PSICX
Price
$50.55
Change
-$0.38 (-0.75%)
Updated
Jun 3 closing price
Net Assets
934.8M
VTSMX
Price
$180.76
Change
-$1.38 (-0.76%)
Updated
Jun 3 closing price
Net Assets
2.2T
Interact to see
Advertisement

PSICX vs VTSMX

Header iconPSICX vs VTSMX Comparison
Open Charts PSICX vs VTSMXBanner chart's image
PSICX vs VTSMX Comparison Chart in %
View a ticker or compare two or three
VS
PSICX vs. VTSMX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSICX is a Hold and VTSMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 2.2T vs. PSICX (935M). VTSMX pays higher dividends than PSICX: VTSMX (0.93) vs PSICX (0.20). PSICX was incepted earlier than VTSMX: PSICX (27 years) vs VTSMX (34 years). PSICX (1.33) is less costly to investors than VTSMX (0.06). PSICX (3.00) and VTSMX (3.00) have comparable annual turnover. VTSMX has a lower initial minimum investment than PSICX: VTSMX (0) vs PSICX (1000). VTSMX annual gain was more profitable for investors over the last year : 27.71 vs. PSICX (18.24). VTSMX return over 5 years is better than : 71.36 vs. PSICX (13.14).
PSICXVTSMXPSICX / VTSMX
Total Expense Ratio1.260.062,100%
Annual Report Gross Expense Ratio1.330.062,217%
Fund Existence27 years34 years-
Gain YTD11.08011.64795%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets935M2.2T0%
Annual Yield % from dividends0.200.9322%
Returns for 1 year18.2427.7166%
Returns for 3 years41.8876.4455%
Returns for 5 years13.1471.3618%
Returns for 10 years22.11260.858%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAGYX24.22N/A
N/A
Putnam Dynamic Asset Allocation Gr Y
CAFFX48.87N/A
N/A
American Funds AMCAP 529F1
DHAMX16.64N/A
N/A
Centre American Select Equity Advisor
HEONX20.96N/A
N/A
Hartford Climate Opportunities C
JACBX20.57N/A
N/A
JHancock Mid Cap Growth I